RA CAPITAL MANAGEMENT, L.P. sold 33.9% of their position (400.41K shares) of VOR BIOPHARMA INC. on the open market
Open‑market sale worth $10.37M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 10/30/2025ACC: 0001231919-25-000395
Director10% Owner
Since Feb 2021
-400.41K
Net shares
Net seller
$10.37M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
400.41K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−87.83K
Price / share
$27.10
Trade value
$2.38M
% of position
7.4%
10/28/2025
1.18M→1.09M
Common Stock
Indirect
Shares
−36.48K
Price / share
$28.18
Trade value
$1.03M
% of position
3.3%
10/28/2025
1.09M→1.06M
Common Stock
Indirect
Shares
−251.52K
Price / share
$25.22
Trade value
$6.34M
% of position
23.8%
10/29/2025
1.06M→804.23K
Common Stock
Indirect
Shares
−24.58K
Price / share
$25.12
Trade value
$617.42K
% of position
3.1%
10/30/2025
804.23K→779.65K
Total
Net shares
−400.41K
Net value
-$10.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/28/2025 | S · Sale | −87.83K | $27.10 | $2.38M | 7.4% | 1.18M | 1.09M |
| Common Stock Indirect | 10/28/2025 | S · Sale | −36.48K | $28.18 | $1.03M | 3.3% | 1.09M | 1.06M |
| Common Stock Indirect | 10/29/2025 | S · Sale | −251.52K | $25.22 | $6.34M | 23.8% | 1.06M | 804.23K |
| Common Stock Indirect | 10/30/2025 | S · Sale | −24.58K | $25.12 | $617.42K | 3.1% | 804.23K | 779.65K |
| Total | −400.41K | -$10.37M | ||||||
Derivative Transactions0
No derivative transactions reported